0001578563-19-000018.txt : 20190529 0001578563-19-000018.hdr.sgml : 20190529 20190529170302 ACCESSION NUMBER: 0001578563-19-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190524 FILED AS OF DATE: 20190529 DATE AS OF CHANGE: 20190529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calias Pericles CENTRAL INDEX KEY: 0001746282 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 19862918 MAIL ADDRESS: STREET 1: C/O CERECOR INC. STREET 2: 400 EAST PRATT STREET, SUITE 606 CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerecor Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-05-24 0 0001534120 Cerecor Inc. CERC 0001746282 Calias Pericles C/O CERECOR INC. 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 0 1 0 0 Chief Scientific Officer Common Stock 2019-05-24 4 A 0 45000 0 A 45000 D Stock Option (Right to Buy) 4.98 2019-05-24 4 A 0 25000 0 A 2029-05-24 Common Stock 25000 25000 D Stock Option (Right to Buy) 4.26 2028-07-16 Common Stock 80000 80000 D Stock Option (Right to Buy) 6.22 2029-04-01 Common Stock 175000 175000 D The restricted stock units vest in four equal installments beginning on July 16, 2019, provided the Reporting Person is then still providing continuous service as an employee, director or consultant. One-fourth of the shares subject to the stock option will vest on July 16, 2019, and the remaining three-fourths of the shares subject to the stock option will vest in substantially equal monthly installments over the following 36 months, provided the Reporting Person is then still providing continuous service as an employee, director or consultant. One-fourth of the shares subject to the stock option will vest on April 1, 2020, and the remaining three-fourths of the shares subject to the stock option will vest in substantially equal monthly installments over the following 36 months. /s/ Donald R. Reynolds, by Power of Attorney 2019-05-29